Skip to main content
Log in

Genetic panel screening in patients with clinically unclassified systemic autoinflammatory diseases

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Objective

Systemic autoinflammatory diseases (SAIDs) may not always present with typical clinical findings of a monogenic disease. We aimed to genetically screen and diagnose these clinically unclassified patients by next-generation sequencing (NGS) analysis.

Method

A total of 64 patients who had clinical findings of a periodic fever syndrome but did not meet the clinical diagnostic criteria for any SAID or had clinical findings for more than one monogenic SAID were identified as “clinically unclassified SAIDs.” NGS panel analysis, including 16 genes, was performed in these patients. Patients, who could not be classified as one of the defined SAID after the result of the NGS gene analysis, were identified as “undefined SAID.”

Results

The most common autoinflammatory symptoms in unclassified SAID patients were abdominal pain (60.9%), arthralgia (48.4%), urticarial rash (43.8%), myalgia (40.6%), oral aphthae (28.1%), and conjunctivitis (20.3%), respectively. In the result of the NGS gene panel screening, pathogenic, likely pathogenic variants, or VUS (variants of uncertain significance) were detected in 36 of 64 patients in at least one gene in the NGS panel. A total of 15 patients were diagnosed with a monogenic SAID according to both phenotypic and genotypic data; 12 patients as FMF, two patients as FCAS, and one patient as TRAPS, respectively. A total of 49 patients who did not meet the classification criteria including genetic results for a monogenic SAID were followed as undefined SAID.

Conclusions

The classification criteria described for SAIDs so far unfortunately do not cover all patients with signs of periodic fevers. The NGS gene panel appears to be a useful diagnostic tool for some of the patients with clinically unclassified SAID findings.

Key Points

• The classification criteria described for SAIDs do not cover all patients with signs of periodic fevers

• The use of the undefined SAID nomenclature will benefit clinicians for diagnosis and initiating early treatment

• The NGS panel appears to be a useful diagnostic tool in patients with clinically unclassified SAIDs

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Federici S, Vanoni F, Ben-Chetrit E, Cantarini L, Frenkel J, Goldbach-Mansky R, for Eurofever and the Pediatric Rheumatology International Trials Organization (PRINTO) et al (2019) An international Delphi survey for the definition of new classification criteria for familial Mediterranean fever, mevalonate kinase deficiency, TNF receptor-associated periodic fever syndromes, and cryopyrin-associated periodic syndrome. J Rheumatol 46:429–436

    Article  PubMed  Google Scholar 

  2. Touitou I, Kone-Paut I (2008) Autoinflammatory diseases. Best Pract Res Clin Rheumatol 22:811–829

    Article  CAS  PubMed  Google Scholar 

  3. Federici S, Sormani MP, Ozen S, Lachmann HJ, Amaryan G, Woo P, Paediatric Rheumatology International Trials Organisation (PRINTO) and Eurofever Project et al (2015) Evidence based provisional clinical classification criteria for auto inflammatory periodic fevers. Ann Rheum Dis 74:799–805

    Article  PubMed  Google Scholar 

  4. Lachmann HJ (2011) Clinical immunology review series: an approach to the patient with a periodic fever syndrome. Clin Exp Immunol 165:301–309

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ter Haar NM, Eijkelboom C, Cantarini L, Papa R, Brogan PA, Kone-Paut I, Eurofever registry and the Pediatric Rheumatology International Trial Organization (PRINTO) et al (2019) Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases. Ann Rheum Dis 78:1405–1411

    Article  PubMed  Google Scholar 

  6. Harrison SR, Mc Gonagle D, Nizam S, Jarrett S, Van der Hilst J, Mc Dermott MF et al (2016) Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined etiology. JCI Insight 1:1–15

    Article  Google Scholar 

  7. Papa R, Rusmini M, Volpi S, Caorsi R, Picco P, Grossi A, et al. (2019) Next generation sequencing panel in undifferentiated autoinflammatory diseases identify patients with colchicine-responder recurrent fevers. Rheumatology (Oxford) 7. https://doi.org/10.1093/rheumatology/kez270

  8. Toplak N, Frenkel J, Ozen S, Lachmann HJ, Woo P, Koné-Paut I, Paediatric Rheumatology International Trials Organisation (PRINTO), Eurotraps and Eurofever Projects et al (2012) An international registry on autoinflammatory diseases: the Eurofever experience. Ann Rheum Dis 71:1177–1182

    Article  PubMed  Google Scholar 

  9. Hoang TK, Albert DA (2018) Novel presentations of periodic fever syndromes: discrepancies between genetic and clinical diagnoses. Eur J Rheumatol 6:1–7

    Google Scholar 

  10. Thomas KT, Feder HM Jr, Lawton AR, Edwards KM (1999) Periodic fever syndrome in children. J Pediatr 135:15–21

    Article  CAS  PubMed  Google Scholar 

  11. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885

    Article  CAS  PubMed  Google Scholar 

  12. Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I, Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO) et al (2019) Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis 78:1025–1032

    Article  CAS  PubMed  Google Scholar 

  13. Shinar Y, Obici L, Aksentijevich I, Bennetts B, Austrup F, Ceccherini I, Costa JM, de Leener A, Gattorno M, Kania U, Kone-Paut I, Lezer S, Livneh A, Moix I, Nishikomori R, Ozen S, Phylactou L, Risom L, Rowczenio D, Sarkisian T, van Gijn M, Witsch-Baumgartner M, Morris M, Hoffman HM, Touitou I, European Molecular Genetics Quality Network (2012) Guidelines for the genetic diagnosis of hereditary recurrent fevers. Ann Rheum Dis 71:1599–1605

    Article  CAS  PubMed  Google Scholar 

  14. Doganay L, Ozdil K, Memisoglu K, Katrinli S, Karakoc E, Nikerel E, Doganay GD (2017) Integrating personalized genomics into Turkish healthcare system: a cancer-oriented pilot activity of Istanbul Northern Anatolian Public Hospitals with GLAB. North Clin Istanb 4:1–3

    PubMed  PubMed Central  Google Scholar 

  15. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–223

    Article  PubMed  PubMed Central  Google Scholar 

  16. Van Gijn ME, Ceccherini I, Shinar Y, Carbo EC, Slofstra M, Arostegui JI et al (2018) New workflow for classification of genetic variants’ pathogenicity applied to hereditary recurrent fevers by the International Study Group for Systemic Autoinflammatory Diseases (INSAID). J Med Genet 55:530–537

    Article  PubMed  Google Scholar 

  17. Brnich SE, Abou Tayoun AN, Couch FJ, Cutting GR, Greenblatt MS, Heinen CD et al (2019) Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework. Genome Med 12:3

    Article  PubMed  PubMed Central  Google Scholar 

  18. Biesecker LG, Harrison SM (2018) The ACMG/AMP reputable source criteria for the interpretation of sequence variants. Genet Med 20:1687–1688

    Article  PubMed  PubMed Central  Google Scholar 

  19. Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY et al (2017) Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet Med 19:1105–1117

    Article  PubMed  PubMed Central  Google Scholar 

  20. De Pieri C, Vuch J, De Martino E, Bianco AM, Ronfani L, Athanasakis E et al (2015) Genetic profiling of autoinflammatory disorders in patients with periodic fever: a prospective study. Pediatr Rheumatol Online J 13:11

    Article  PubMed  PubMed Central  Google Scholar 

  21. Karacan İ, Balamir A, Uğurlu S, Aydın AK, Everest E, Zor S, Önen MÖ, Daşdemir S, Özkaya O, Sözeri B, Tufan A, Yıldırım DG, Yüksel S, Ayaz NA, Ömeroğlu RE, Öztürk K, Çakan M, Söylemezoğlu O, Şahin S, Barut K, Adroviç A, Seyahi E, Özdoğan H, Kasapçopur Ö, Turanlı ET (2019) Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study. Rheumatol Int 39:911–919

    Article  CAS  PubMed  Google Scholar 

  22. Al-Khafaji J, Ganz-Lord F, Konjeti VR, Viny AD (2018) A case of familial Mediterranean fever with extensive lymphadenopathy and complex heterozygous genotype presenting in the fourth decade. Case Rep Rheumatol 2018:9670801

    PubMed  PubMed Central  Google Scholar 

  23. Aslan M, Demir G, Esen R, Dülger AC, Beğenik H, Çelik Y et al (2012) A rare cause of massive ascites: familial Mediterranean fever. Turk J Gastroenterol 23:290–293

    Article  PubMed  Google Scholar 

  24. Tanatar A, Sönmez HE, Karadağ ŞG, Çakmak F, Çakan M, Demir F et al (2019) Performance of Tel-Hashomer, Livneh, pediatric and new Eurofever/PRINTO classification criteria for familial Mediterranean fever in a referral center. Rheumatol Int 10. https://doi.org/10.1007/s00296-019-04463-w

  25. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Turkish FMF Study Group et al (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11

    Article  Google Scholar 

  26. Barut K, Sahin S, Adrovic A, Sinoplu AB, Yucel G, Pamuk G, Aydın AK, Dasdemir S, Turanlı ET, Buyru N, Kasapcopur O (2018) Familial Mediterranean fever in childhood: a single-center experience. Rheumatol Int 38:67–74

    Article  CAS  PubMed  Google Scholar 

  27. Milhavet F, Cuisset L, Hoffman HM, Slim R, El-Shanti H, Aksentijevich I et al (2008) The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat 29:803–808

    Article  PubMed  Google Scholar 

  28. Naselli A, Penco F, Cantarini L, Insalaco A, Alessio M, Tommasini A, Maggio C, Obici L, Gallizi R, Cimmino M, Signa S, Lucherini OM, Carta S, Caroli F, Martini A, Rubartelli A, Ceccherini I, Gattorno M (2016) Clinical characteristics of patients carrying the Q703K variant of the NLRP3 gene: a 10-year multicentric national study. J Rheumatol 43:1093–1100

    Article  CAS  PubMed  Google Scholar 

  29. Verma D, Sarndahl E, Andersson H, Eriksson P, Fredrikson M, Jonsson JI et al (2012) The Q705K polymorphism in NLRP3 is a gain-of function alteration leading to excessive interleukin-1 beta and IL-18 production. PLoS One 7:e34977

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Verma D, Lerm M, Blomgran Julinder R, Eriksson P, Söderkvist P, Särndahl E (2008) Gene polymorphisms in the NALP3 inflammasome are associated with interleukin-1 production and severe inflammation: relation to common inflammatory diseases? Arthritis Rheum 58:888–894

    Article  CAS  PubMed  Google Scholar 

  31. Levy R, Gérard L, Kuemmerle-Deschner J, Lachmann HJ, Koné-Paut I, Cantarini L, Woo P, Naselli A, Bader-Meunier B, Insalaco A, al-Mayouf SM, Ozen S, Hofer M, Frenkel J, Modesto C, Nikishina I, Schwarz T, Martino S, Meini A, Quartier P, Martini A, Ruperto N, Neven B, Gattorno M, for PRINTO and Eurofever (2015) Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry. Ann Rheum Dis 74:2043–2049

    Article  CAS  PubMed  Google Scholar 

  32. Papa R, Doglio M, Lachmann HJ, Ozen S, Frenkel J, Simon A, Paediatric Rheumatology International Trials Organisation (PRINTO) and the Eurofever Project et al (2017) A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry. Orphanet J Rare Dis 12:167

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We are grateful to all participating children and their families.

Author information

Authors and Affiliations

Authors

Contributions

B.S., F.D. and N.A.A. developed the concept and designed research; F.D., H.E.S., S.G.K., B.S., and N.A. performed research and acquired data; Ö.A.D., Y.K.D., K.E.T., S.C., and H.LD. analyzed data; F.D., B.S., N.A.A., Ö.A.D., Y.K.D., K.E.T., S.C., and H.L.D. interpreted data; F.D. and B.S. wrote and reviewed the manuscript.

Corresponding author

Correspondence to Ferhat Demir.

Ethics declarations

Disclosures

None

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 24 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Demir, F., Doğan, Ö.A., Demirkol, Y.K. et al. Genetic panel screening in patients with clinically unclassified systemic autoinflammatory diseases. Clin Rheumatol 39, 3733–3745 (2020). https://doi.org/10.1007/s10067-020-05108-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-020-05108-1

Keywords

Navigation